Skip to content

Antibiotic Prophylaxis in Prelabor Rupture of Membranes at Term

Antibiotic Prophylaxis in Prelabor Rupture of Membranes at Term - a Randomized Controlled Trial

Status
Completed
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01633294
Enrollment
161
Registered
2012-07-04
Start date
2008-10-31
Completion date
2012-01-31
Last updated
2016-11-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chorioamnionitis, Neonatal Early Onset Sepsis, Neonatal Meningitis, Neonatal Pneumonia, Puerperal Endometritis

Keywords

premature rupture of membranes, term pregnancy, chorioamnionitis, endometritis, neonatal sepsis, antibiotic prophylaxis

Brief summary

The aims of this study are to determine whether antibiotics administered routinely in women presenting with premature rupture of membranes later than the 37+0 weeks of gestation can alter the rate of maternal and neonatal infection and to compare these rates between prompt (\< 12 hour) and delayed (≥ 12 hour) induction in the group of patients not submitted to antibiotic prophylaxis.

Interventions

ampicillin 1 g every six hours and gentamicin 240 mg every day intravenously

Sponsors

Hospital de Santa Maria, Portugal
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

* term (≥ 37+0 weeks) singleton pregnancy * a vertex presentation * ruptured membranes for less than 12 hours * negative Group B Streptococcus (GBS) culture performed between 35 and 37 weeks

Exclusion criteria

* active labor * absence of GBS culture or indication for GBS antibiotic prophylaxis (such as maternal GBS colonization between 35 and 37 weeks, GBS bacteriuria, prior infant with GBS sepsis) * contraindication to expectant management (such as fetal distress, meconium staining of the amniotic fluid or chorioamnionitis) or to vaginal delivery

Design outcomes

Primary

MeasureTime frameDescription
neonatal infection rateparticipants will be followed for the duration of hospital stay, an expected average of 3 daysneonatal infection rate includes early onset sepsis, meningitis and pneumonia
maternal infection rateparticipants will be followed for the duration of hospital stay, an expected average of 3 daysmaternal infection rate includes chorioamnionitis or puerperal endometritis

Secondary

MeasureTime frameDescription
comparison of the infection rates between prompt and delayed inductionparticipants will be followed for the duration of hospital stay, an expected average of 3 daysrate of maternal and neonatal infection between prompt (\<12h) and delayed induction (≥12h) in the group of patients not submitted to antibiotic prophylaxis

Countries

Portugal

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 25, 2026